Panduratin A, a Possible Inhibitor in Metastasized A549 Cells through Inhibition of NF-Kappa B Translocation and Chemoinvasion

p53-regulierende Signaltransduktionskaskaden als Ziele für eine personalisierte Krebstherapie

(2013) K. Höpker et al.   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT

Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding

(2013) Roberta Rizzo et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Matrix Metalloproteinases in Health and Disease: Insights From Dermatopathology

(2012) Marier Hernández-Pérez et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Cancer metabolism: Key players in metabolic reprogramming

(2012) Tomoyoshi Soga   CANCER SCIENCE

Role of Nuclear Factor-ĸB in Breast and Colorectal Cancer

(2012) Adeel Zubair et al.   CURRENT ALLERGY AND ASTHMA REPORTS

p53 mutations in cancer

(2012) Patricia A. J. Muller et al.   NATURE CELL BIOLOGY

In Vitro and In Vivo Anti-Angiogenic Activities of Panduratin A

(2012) Siew-Li Lai et al.   PLoS One

The matrix metalloproteinase-7 regulates the extracellular shedding of syndecan-2 from colon cancer cells

(2011) Sojoong Choi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Panduratin A Inhibits the Growth of A549 Cells through Induction of Apoptosis and Inhibition of NF-KappaB Translocation

(2011) Shiau-Chuen Cheah et al.   MOLECULES

Role of NF-kB, p53, and p21 in the Regulation of TNF-α Mediated Apoptosis of Lymphocytes

(2010) N. V. Ryazantseva et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Potential pharmacological control of the NF-κB pathway

(2009) Gautam Sethi et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

CDK Inhibitors: Cell Cycle Regulators and Beyond

(2008) Arnaud Besson et al.   DEVELOPMENTAL CELL

Antiangiogenic effects of flavonoids and chalcones

(2008) J MOJZIS et al.   PHARMACOLOGICAL RESEARCH

Matrix metalloproteinases as modulators of inflammation

(2007) A MANICONE et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY